Peripheral Nk Cell Lymphoma

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2022-10-21
Clinical Trial Update: A Phase II Study of Linperlisib (YY-20394) in Patients With Relapsed or Refractory Peripheral T/NK Cell Lymphoma [Phase 2]
Phase II clinical trial of Linperlisib (YY-20394) in relapsed or refractory peripheral T/NK cell lymphoma is reported as a Phase 2 study.